Determinants of survival after first relapse of acute lymphoblastic leukemia: a Children's Oncology Group study

被引:11
作者
Rheingold, Susan R. [1 ,2 ]
Bhojwani, Deepa [3 ,4 ]
Ji, Lingyun [5 ]
Xu, Xinxin [6 ]
Devidas, Meenakshi [7 ]
Kairalla, John A. [8 ]
Shago, Mary [9 ]
Heerema, Nyla A. [10 ]
Carroll, Andrew J. [11 ]
Breidenbach, Heather [12 ]
Borowitz, Michael [13 ]
Wood, Brent L. [14 ]
Angiolillo, Anne L. [15 ]
Asselin, Barbara L. [16 ]
Bowman, W. Paul [17 ]
Brown, Patrick [18 ]
Dreyer, ZoAnn E. [19 ]
Dunsmore, Kimberly P. [20 ]
Hilden, Joanne M. [21 ,22 ]
Larsen, Eric [23 ]
Maloney, Kelly [21 ,22 ]
Matloub, Yousif [24 ]
Mattano, Leonard A. [25 ]
Winter, Stuart S. [26 ]
Gore, Lia [21 ,22 ]
Winick, Naomi J. [27 ]
Carroll, William L. [28 ]
Hunger, Stephen P. [1 ,2 ]
Raetz, Elizabeth A. [28 ]
Loh, Mignon L. [29 ]
机构
[1] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA
[2] Univ Penn, Childrens Hosp Philadelphia, Ctr Childhood Canc Res, Perelman Sch Med, Philadelphia, PA 19104 USA
[3] Univ Southern Calif, Childrens Hosp Los Angeles, Norris Comprehens Canc Ctr, Div Pediat Hematol Oncol, Los Angeles, CA USA
[4] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA
[5] Univ Southern Calif, Keck Sch Med, Dept Populat & Publ Hlth Sci, Los Angeles, CA USA
[6] Childrens Oncol Grp, Monrovia, CA USA
[7] St Jude Childrens Res Hosp, Dept Global Pediat Med, Memphis, TN USA
[8] Univ Florida, Dept Biostat, Gainesville, FL USA
[9] Univ Toronto, Hosp Sick Children, Dept Lab Med & Pathobiol, Toronto, ON, Canada
[10] Ohio State Univ, Dept Pathol, Columbus, OH USA
[11] Univ Alabama Birmingham, Dept Genet, Birmingham, AL USA
[12] Hosp Sick Children, Toronto, ON, Canada
[13] Johns Hopkins Med Inst, Dept Pathol & Oncol, Baltimore, MD USA
[14] Univ Southern Calif, Childrens Hosp Los Angeles, Keck Sch Med, Dept Pathol & Lab Med, Los Angeles, CA USA
[15] Servier Pharmaceut, Boston, MA USA
[16] Univ Rochester, Golisano Childrens Hosp, Dept Pediat, Med Ctr,Wilmot Canc Ctr, Rochester, NY USA
[17] Cook Childrens Med Ctr, Ft Worth, TX USA
[18] Bristol Myers Squibb, Princeton, NJ USA
[19] Texas Childrens Hosp, Baylor Coll Med, Dept Pediat, Sect Hematol Oncol, Houston, TX USA
[20] Univ Virginia, Sch Med, Dept Pediat, Charlottesville, VA USA
[21] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA
[22] Childrens Hosp Colorado, Ctr Canc & Blood Disorders, Aurora, CO USA
[23] Maine Med Ctr, Dept Pediat, Portland, ME USA
[24] Case Western Reserve Univ, Dept Pediat, Cleveland, OH USA
[25] HARP Pharm Consulting, Mystic, CT USA
[26] Childrens Minnesota, Canc & Blood Disorders Program, Minneapolis, MN USA
[27] Univ Texas Southwestern Med Ctr, Dept Pediat, Childrens Hlth, Dallas, TX USA
[28] NYU Grossman Sch Med, Dept Pediat, Perlmutter Canc Ctr, New York, NY USA
[29] Seattle Childrens Hosp, Dept Pediat, Seattle, WA USA
基金
美国国家卫生研究院;
关键词
ACUTE LYMPHOCYTIC-LEUKEMIA; MINIMAL RESIDUAL DISEASE; HIGH-DOSE METHOTREXATE; B-CELL PRECURSOR; HIGH-RISK; STANDARD-RISK; CLONAL ORIGINS; YOUNG-ADULTS; CHEMOTHERAPY; THERAPY;
D O I
10.1038/s41375-024-02395-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Limited prognostic factors have been associated with overall survival (OS) post-relapse in childhood Acute Lymphoblastic Leukemia (ALL). Patients enrolled on 12 Children's Oncology Group frontline ALL trials (1996-2014) were analyzed to assess for additional prognostic factors associated with OS post-relapse. Among 16,115 patients, 2053 (12.7%) relapsed. Relapse rates were similar for B-ALL (12.5%) and T-ALL (11.2%) while higher for infants (34.2%). Approximately 50% of B-ALL relapses occurred late (>= 36 months) and 72.5% involved the marrow. Conversely, 64.8% of T-ALL relapses occurred early (<18 months) and 47.1% involved the central nervous system. The 5-year OS post-relapse for the entire cohort was 48.9 +/- 1.2%; B-ALL:52.5 +/- 1.3%, T-ALL:35.5 +/- 3.3%, and infant ALL:21.5 +/- 3.9%. OS varied by early, intermediate and late time-to-relapse; 25.8 +/- 2.4%, 49.5 +/- 2.2%, and 66.4 +/- 1.8% respectively for B-ALL and 29.8 +/- 3.9%, 33.3 +/- 7.6%, 58 +/- 9.8% for T-ALL. Patients with ETV6::RUNX1 or Trisomy 4 + 10 had median time-to-relapse of 43 months and higher OS post-relapse 74.4 +/- 3.1% and 70.2 +/- 3.6%, respectively. Patients with hypodiploidy, KMT2A-rearrangement, and TCF3::PBX1 had short median time-to-relapse (12.5-18 months) and poor OS post-relapse (14.2 +/- 6.1%, 31.9 +/- 7.7%, 36.8 +/- 6.6%). Site-of-relapse varied by cytogenetic subtype. This large dataset provided the opportunity to identify risk factors for OS post-relapse to inform trial design and highlight populations with dismal outcomes post-relapse.
引用
收藏
页码:2382 / 2394
页数:13
相关论文
共 41 条
[1]   Pharmacokinetic and Pharmacodynamic Properties of Calaspargase Pegol Escherichia coli L-Asparaginase in the Treatment of Patients With Acute Lymphoblastic Leukemia: Results From Children's Oncology Group Study AALL07P4 [J].
Angiolillo, Anne L. ;
Schore, Reuven J. ;
Devidas, Meenakshi ;
Borowitz, Michael J. ;
Carroll, Andrew J. ;
Gastier-Foster, Julie M. ;
Heerema, Nyla A. ;
Keilani, Taha ;
Lane, Ashley R. ;
Loh, Mignon L. ;
Reaman, Gregory H. ;
Adamson, Peter C. ;
Wood, Brent ;
Wood, Charlotte ;
Zheng, Hao W. ;
Raetz, Elizabeth A. ;
Winick, Naomi J. ;
Carroll, William L. ;
Hunger, Stephen P. .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (34) :3874-U276
[2]   Effectiveness of high-dose methotrexate in T-cell lymphoblastic leukemia and advanced-stage lymphoblastic lymphoma: a randomized study by the Children's Oncology Group (POG 9404) [J].
Asselin, Barbara L. ;
Devidas, Meenakshi ;
Wang, Chenguang ;
Pullen, Jeanette ;
Borowitz, Michael J. ;
Hutchison, Robert ;
Lipshultz, Steven E. ;
Camitta, Bruce M. .
BLOOD, 2011, 118 (04) :874-883
[3]   Relapsed childhood acute lymphoblastic leukaemia [J].
Bhojwani, Deepa ;
Pui, Ching-Hon .
LANCET ONCOLOGY, 2013, 14 (06) :E205-E217
[4]   Augmented Therapy Improves Outcome for Pediatric High Risk Acute Lymphocytic Leukemia: Results Of Children's Oncology Group Trial P9906 [J].
Bowman, W. Paul ;
Larsen, Eric L. ;
Devidas, Meenakshi ;
Linda, Stephen B. ;
Blach, Laurie ;
Carroll, Andrew J. ;
Carroll, William L. ;
Pullen, D. Jeanette ;
Shuster, Jonathan ;
Willman, Cheryl L. ;
Winick, Naomi ;
Camitta, Bruce M. ;
Hunger, Stephen P. ;
Borowitz, Michael J. .
PEDIATRIC BLOOD & CANCER, 2011, 57 (04) :569-577
[5]   Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia A Randomized Clinical Trial [J].
Brown, Patrick A. ;
Ji, Lingyun ;
Xu, Xinxin ;
Devidas, Meenakshi ;
Hogan, Laura E. ;
Borowitz, Michael J. ;
Raetz, Elizabeth A. ;
Zugmaier, Gerhard ;
Sharon, Elad ;
Bernhardt, Melanie B. ;
Terezakis, Stephanie A. ;
Gore, Lia ;
Whitlock, James A. ;
Pulsipher, Michael A. ;
Hunger, Stephen P. ;
Loh, Mignon L. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (09) :833-842
[6]  
Brown PA, 2021, LEUKEMIA, V35, P1279, DOI 10.1038/s41375-021-01177-6
[7]   Childhood Acute Lymphoblastic Leukemia: Results of the Randomized Acute Lymphoblastic Leukemia Intercontinental-Berlin-Frankfurt-MUnster 2009 Trial [J].
Campbell, Myriam ;
Kiss, Csongor ;
Zimmermann, Martin ;
Riccheri, Cecilia ;
Kowalczyk, Jerzy ;
Felice, Maria S. ;
Kuzmanovic, Milos ;
Kovacs, Gabor ;
Kosmidis, Helen ;
Gonzalez, Alejandro ;
Bilic, Ernest ;
Castillo, Luis ;
Kolenova, Alexandra ;
Jazbec, Janez ;
Popa, Alexander ;
Konstantinov, Dobrin ;
Kappelmayer, Janos ;
Szczepanski, Tomasz ;
Dworzak, Michael ;
Buldini, Barbara ;
Gaipa, Giuseppe ;
Marinov, Neda ;
Rossi, Jorge ;
Nagy, Attila ;
Gaspar, Imre ;
Stary, Jan ;
Schrappe, Martin .
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (19) :3499-+
[8]  
COX DR, 1984, ANAL SURVIVAL DATA
[9]  
den Boer ML, 2021, LANCET HAEMATOL, V8, pE55, DOI 10.1016/S2352-3026(20)30353-7
[10]   Intensified Chemotherapy Without Sct in Infant All: Results From COG P9407 (Cohort 3) [J].
Dreyer, ZoAnn E. ;
Hilden, Joanne M. ;
Jones, Tamekia L. ;
Devidas, Meenakshi ;
Winick, Naomi J. ;
Willman, Cheryl L. ;
Harvey, Richard C. ;
Chen, I-Ming ;
Behm, Fred G. ;
Pullen, Jeanette ;
Wood, Brent L. ;
Carroll, Andrew J. ;
Heerema, Nyla A. ;
Felix, Carolyn A. ;
Robinson, Blaine ;
Reaman, Gregory H. ;
Salzer, Wanda L. ;
Hunger, Stephen P. ;
Carroll, William L. ;
Camitta, Bruce M. .
PEDIATRIC BLOOD & CANCER, 2015, 62 (03) :419-426